QUOTE AND NEWS
SeekingAlpha  Jul 18  Comment 
Track how today's Stocks To Watch are performing here. To send in your own ideas for next week's Stocks To Watch, email stockstowatch@seekingalpha.com before 6:00 AM ET Monday. Idenix Pharmaceuticals ( IDIX ) - long - ...
Benzinga  Jul 3  Comment 
The hepatitis C industry has been on fire since Merck (NYSE: MRK) paid a 230 percent premium for pharmaceutical company Idenix (NASDAQ: IDIX). Benzinga spoke to Enanta (NASDAQ: ENTA) CEO Jay Luly about possibilities for his firm, which has one...
Benzinga  Jun 27  Comment 
Merck (NYSE: MRK) paid a 230 percent premium for Hepatitis C-focused Idenix Pharmaceuticals (NASDAQ: IDIX). News of the massive acquisition, earlier this month, sent shares of other Hep C companies, Enanta (NASDAQ: ENTA) and Achillion (NASDAQ:...
Benzinga  Jun 20  Comment 
Baird analyst Brian Skorney reported on “increasingly bullish” share action of Achillion Pharmaceuticals (NASDAQ: ACHN) following SEC filing by Idenix Pharmaceuticals (NASDAQ: IDIX). Skorney remarked that Achillion's stock action has been...
SeekingAlpha  Jun 20  Comment 
ByAustrolib: Merck's (MRK) acquisition of Idenix (IDIX) for its hepatitis C [HCV] platform has certainly created a storm of chatter in the investment community. 12 articles have been published on Seeking Alpha alone on the merger since the $3.85B...
newratings.com  Jun 20  Comment 
WHITEHOUSE STATION (dpa-AFX) - Merck (MRK), known as MSD outside the U.S. and Canada, is commencing today, through a subsidiary, a cash tender offer to buy all outstanding common shares of Idenix Pharmaceuticals, Inc. (IDIX). On June 09, 2014,...
Motley Fool  Jun 17  Comment 
Merck has been taking heat for the price it paid for Idenix -- Here's why it actually isn't as crazy as it sounds.
DailyFinance  Jun 17  Comment 
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Idenix Pharmaceuticals, Inc. (“Idenix” or...
SeekingAlpha  Jun 16  Comment 
By Weighing Machine: Achillion (ACHN) shares have rallied an astounding 165% ($450 million increase in market value) following the news that Idenix (IDIX) would be acquired by Merck (MRK) for nearly $4 billion (a 240% premium to its share price)....
Motley Fool  Jun 14  Comment 
Five clinical updates that made waves in the biotech sector this week, as well as the surprising buyout that still has Wall Street abuzz.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki